Asthma support nurse
The clinical nurse specialist (CNS) team for adult asthma works closely with a multidisciplinary team composed of:
The team also incorporates allergy and occupational asthma CNSs to deliver personalised care and support for individuals living with severe asthma in order to effectively manage their condition as both in- and outpatients.
The asthma CNS team provides the following services:
- telephone and email support
- asthma management plans
homecare therapies (sub-cutaneous terbutaline).
anti-IgE (Xolair) therapy
complex asthma interventions
specialist asthma clinics
inpatient review and education
training for ward nurses, cardiothoracic MSc nursing students, local asthma nurse specialist teams and primary care nurses
transition clinics and support.
Lead nurse, Suzie, provides clinical review and disease management for all patients admitted for the systematic assessment of refractory asthma (SARA). Her specialist interests include the psychosocial impact of severe asthma and the transition of adolescent patients from paediatric care to adult services.
Rachel is responsible for the daily running of the anti-IgE omalizumab (Xolair) service, providing education for patients embarking on therapy, reviewing their progress and repatriating care to other centres where appropriate. She coordinates monthly Xolair multi-disciplinary team meetings in order to assess the eligibility of individuals for anti-IgE therapy.
Anti-IgE (omalizumab/Xolair) service
Omalizumab (Xolair) is given in injection form to reduce the symptoms of asthma. It is offered to patients who have severe allergic asthma that does not respond to inhaled or oral asthma therapies, including high oral corticosteroid use. It works by reducing the effects of inflammatory cells which cause asthma symptoms.
The Xolair clinic runs five days a week (Monday to Friday) in Lind ward. More than 90 patients receive therapy on a two or four weekly basis.
Patients must complete a 16-week assessment of the therapy during which objective measures of symptom improvements are reviewed and a clinical decision made in conjunction with the lead consultant before continuation of the lifelong treatment.
Read about our clinical nurse specialists in occupational and environmental lung disease